Anthem (ANTM) Raises Quarterly Dividend 7.1% to $0.75; 1.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Anthem (ANTM) Appoints Bahija Jallal to Board
January 31, 2018 6:07 AM ESTAnthem, Inc. (NYSE: ANTM) announced today that Bahija Jallal, PhD, has been named to its Board of Directors effective February 1, 2018.
With more than 25 years of leadership experience and expertise in the biopharmaceutical industry, Dr. Jallals science-driven leadership combined with her passion to improve the lives of patients will be an asset to Anthems Board as they guide the Company... More
Anthem (ANTM) Tops Q4 EPS by 2c
January 31, 2018 6:05 AM ESTAnthem (NYSE: ANTM) reported Q4 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $22.4 billion versus the consensus estimate of $22.25 billion.
We are pleased with our 2017 performance, which is the result of improved execution in all areas of our business and an increased focus on... More
